Combination of high levels of fibrinogen and high sensitivity C-reactive protein enhances risk of acute coronary syndrome

ISTH Academy, Chananikan Makmool, 264353

Demographic, clinical and hematological predictors of carotid atherosclerotic plaque histology

ISTH Academy, Gian Luca Salvagno, 264356

Endocan and homocysteine levels in Brazilian Renal Transplant Recipients

ISTH Academy, Luci Dusse, 264357

The Role of HLA-class-II (HLAcII) Molecules in Determining the Immunogenicity Potential of Therapeutic Factor VIII Proteins (tFVIIIs) in Hemophilia A (HA): The Gate Keeper Hypothesis

ISTH Academy, Vincent P. Diego, 264374

Modulation of the FVIII-specific Immune Response by CD4+CD25+Foxp3+ Regulatory T cells

ISTH Academy, Mirjam Meissner, 264375

Assessment of single-factor deficiency sensitivity of three APTT reagents

ISTH Academy, Claire Martin, 264376

Relationship of markers of inflammation, infection, and endothelial function to mortality and severity of coagulopathy in patients with sepsis-associated DIC

ISTH Academy, Matthew Rondina, 264391

Thrombin Time Test of Patients with Liver Disease attending Medicine outpatient Department UCTH, Calabar, Nigeria

ISTH Academy, Dorathy Chioma Okpokam, 264392

Increased platelet contribution to clot strength in cirrhotic patients with non-malignant recent portal vein thrombosis

ISTH Academy, Ecaterina Scarlatescu, 264393

Assessment of thrombomodulin resistance in women using second generation, third generation and progestin-only contraceptives

ISTH Academy, Laure Morimont, 264408

Validation of an original ETP-based APC resistance assay for the evaluation of prothrombotic states

ISTH Academy, Laure Morimont, 264409

Data interpretation of the ETP-based APC resistance assay and the concept of nAPCsr10, an improved nAPCsr

ISTH Academy, Laure Morimont, 264410

A proximity-based in silicoapproach to identify redox-labile disulfide bonds: the example of FVIII

ISTH Academy, Carmen Coxon, 264426

Identification and molecular characterization of alternatively spliced novel isoforms of human antithrombin gene

ISTH Academy, SAYEED UR REHMAN ABUL KALAM, 264427

Effect of catechins on blood coagulation and on various proteins related to the regulation of blood coagulation which are produced in HepG2 Cells

ISTH Academy, Tatsuya Hayashi, 264428

Compared with P-selectin and lysosomal associated membrane protein 3, TREM-like transcript 1 is a more sensitive marker of platelet activation in patients with acute coronary syndromes

ISTH Academy, Shundong Ji, 264445

Absence of measurable contact system activation of coagulation during hemodialysis: a randomized crossover study

ISTH Academy, Christelle Orlando, 264447

Potential role of high-sensitive troponin T in identification of patients with pulmonary embolism (PE) who may be treated safely at home?

ISTH Academy, Stephan Hendriks, 264448

Biomarkers for prediction of thromboembolic disease

ISTH Academy, Mikkel Lundbech, 264464

Plasma fibrin clot proteomics in healthy subjects: relation to clot permeability and lysis time

ISTH Academy, Anetta Undas, 264465

No change in coagulation factor levels after knee arthroscopy

ISTH Academy, Carolina Eveline Touw, 264466

The Predictive Value of Right Ventricle Strain assessed by CTPA compared to the Simplified Pulmonary Embolism Severity Index for 30 day Mortality in Outpatients Presenting with Symptomatic Pulmonary Embolism

ISTH Academy, Ming Sheng Lim, 264481

Serum lipoprotein (a) is not increased in patients with previous spontaneous venous thrombosis or correlated with global fibrinolysis

ISTH Academy, Andreza Lamônica, 264482

TEG-BASED EVALUATION OF GENDER-ASSOCIATED HYPERCOAGULABILITY

ISTH Academy, Kristen Carter, 264483

Discrepancy between clotting versus chromogenic FVIII procoagulant assay is determined by a combination of APTT reagent and FVIII-deficient plasma

ISTH Academy, Atsuo Suzuki, 264498

Performance Evaluation of a Homogeneous Research Prototype Immunoassay for the Detection of Emicizumab in Human Plasma on an Automated Coagulation Analyzer

ISTH Academy, Silke Echternacht, 264499

Comparison of one stage APTT FVIII assay and chromogenic factor (F) VIII assays in patients with severe Haemophilia A, receiving FVIII treatment products

ISTH Academy, Anne Riddell, 264500

Sensitive method for diagnosing a platelet population behavior after stimulation

ISTH Academy, Alena Litvinenko, 264515

Mean platelet volume and blood loss in total hip replacement surgery

ISTH Academy, Irina P. Antropova, 264516

Phenotypic Variability in Antiplatelet and Anticoagulant Therapy in African Americans: An ACCOuNT Consortium Study

ISTH Academy, Minoli Perera, 264517

Fibrinogenolytic effects of Night Adder snake venoms

ISTH Academy, Francisco Coimbra, 264535

Levels of Factor XII and Plasmin-antiplasmin Complex Serum in Acute Coronary Syndrome Patients

ISTH Academy, Irza Wahid, 264536

A multimodal approach using tranexamic acid plus fibrinogen compensates low levels of thrombin generation following PCC therapy in a polytrauma model

ISTH Academy, Oliver Grottke, 264537

Characterization of the coagulopathy in patients treated with extracorporeal membrane oxygenation: conventional coagulation assays versus “Point of Care” analyses

ISTH Academy, Andreas Straub, 264555

Single center analysis of clinical characteristics and outcomes of patients with acquired hemophilia A

ISTH Academy, Yoshiyuki Ogawa, 264556

Outcome of CARE: A 6-year national registry of acquired hemophilia A in China

ISTH Academy, Boyang Sun, 264557

Peptides derived from basement membrane hydrolysis by snake venom metalloproteinases contribute to the vascular effects of viper venoms

ISTH Academy, Ana M. Moura-da-Silva, 264558

Use of a thrombin generation assay and thromboelastometry in the assessment of the efficacy of treatment with activated prothrombin complex concentrate (APCC) or recombinant Factor VIIa (rFVIIa) concentrate in patients with acquired haemophilia and in patients with haemophilia A with inhibitor - a multicenter study

ISTH Academy, Krystyna Zawilska, 264571

Acquired hemophilia A presenting in a 13 year-old boy - A Clinical Case

ISTH Academy, Rute Preto, 264572

BLEEDING COMPLICATIONS AFTER PERCUTANEOUS RENAL BIOPSY: Analysis of probable risk factors

ISTH Academy, Veronica Privitera, 264573

Combination of cyclophosphamide and corticosteroids therapy facilitate remission in acquired hemophilia A patients with high titers of inhibitors: A single center experience in China

ISTH Academy, Naifang Ye, 264574

Evaluation of Intracranial Haemorrhage in Patients with Congenital Factor Deficiencies:A Single-Center Experience from Turkey

ISTH Academy, Murat Soker, 264588

Use of rFIX-FP in a child with mild hemophilia B during a surgical procedure

ISTH Academy, John Puetz, 264589

Psychosocial issues in mothers of children with hemophilia

ISTH Academy, Aya Nakao, 264590

Long-term safety of N8-GP (turoctocog alfa pegol) prophylaxis in patients with severe haemophilia A

ISTH Academy, Nicola J Curry, 264591

Measuring Health Related Quality of Life (HRQoL) in Boys with Hemophilia using Extended Half-Life Clotting Factor Concentrates (CFCs)

ISTH Academy, Victoria Price, 264605

Changes in bleeding symptoms and daily life with emicizumab prophylaxis: a questionnaire in patients with hemophilia A (PwHA) without FVIII inhibitors in a long-term phase 1/2 study

ISTH Academy, Midori Shima, 264606

The Outcome of Intermediate-Dose Prophylaxis and On-Demand Episodic Treatment for Severe Hemophilia A Patients in Taiwan - A Longitudinal Study

ISTH Academy, Shyh-Shin Chiou, 264607

Haemostatic therapy for insertion of central venous access devices in severe haemophilia A and B - Melbourne paediatric protocol

ISTH Academy, Sally Campbell, 264608

Various complications after vascular procedure in patients with hemophilia

ISTH Academy, Eun Jin Choi, 264621

Cardiovascular clinical and laboratory profiles of hemophilia patients from the Brazilian Hemophilia Treatment Center of Pernambuco (HEMOPE)

ISTH Academy, Ricardo Camelo, 264622

Low-dose immune tolerance induction strategy eradicates high-titer inhibitor with poor risk(s) in hemophilia A children: a pilot study in China

ISTH Academy, Zekun Li, 264623

PRactical Utilisation of Octapharma FVIII Concentrates in Previously Untreated and Minimally Treated Haemophilia A Patients Entering Routine Clinical Treatment with Nuwiq®, Octanate® or Wilate® - The Protect-NOW Study

ISTH Academy, Johannes Oldenburg, 264638

Immune Tolerance Induction for the Hemophilia A Inhibitor Patients with poor prognostic Factors

ISTH Academy, Soon Ki Kim, 264639

Target joint resolution in patients with hemophilia A receiving long-term prophylaxis with BAY 94-9027

ISTH Academy, Mark Reding, 264640

Utility of an educational material for primary caregivers of pediatric patients with Hemophilia

ISTH Academy, Mashenka Moreno, 264654

A Case Series of Continuous Infusion with Kovaltry® (Octocog Alfa) in Patients with Hemophilia A

ISTH Academy, Georgina Floros, 264655

Haemophilia B minor- lab error or possible misdiagnosis

ISTH Academy, Florije Raka, 264657

Adherence to Prophylaxis in Hemophilia and von Willebrand Disease: Systematic Assessment from an Electronic Diary

ISTH Academy, Andreas Tiede, 264674

Seek and Ye Shall Find - elearning as a method to improve knowledge of bleeding management

ISTH Academy, Louise English, 264675

Clinically guided 4 factor prothrombin complex concentrate therapy in cardiac surgery is not associated with a sustained procoagulant state

ISTH Academy, Oliver Grottke, 264676

Plasmodium falciparum histidine rich protein HRPII inhibits the anti-inflammatory function of antithrombin

ISTH Academy, Alireza Rezaie, 264691

Regulation of vascular inflammation and liver defense system by a lipid substrate of N-terminal phosphatase of soluble epoxide hydrolase

ISTH Academy, Eriko Suzuki, 264692

Partially methylated domains of fetal and adult Liver sinusoidal endothelial cells revealed cell-type as well as differentiation-stage specificity

ISTH Academy, Muhammad Ahmer Jamil, 264693

Remote ischemic preconditioning does not influence lectin pathway protein levels in cancer patients undergoing surgery: a randomized controlled trial

ISTH Academy, Kristine Frederiksen, 264708

Modulation of the Liver Immune Microenvironment by an Adeno-Associated Virus Serotype 8 (AAV8) Gene Therapy Vector

ISTH Academy, Agostina Carestia, 264709

MiR-146a participates in thrombo-inflammation regulating neutrophil extracellular trap formation

ISTH Academy, Ana Belen Arroyo Rodriguez, 264710

Outside-in integrin signaling induces Disabled-2 (Dab2) Ser24 phosphorylation causing Dab2 dissociation from phosphatidic acid in human platelets

ISTH Academy, Ching-Ping Tseng, 264724

Plasma Inhibitors of Platelet Sheddase Activity - Rocks to the Scissors on the Paper

ISTH Academy, Christine Lee, 264725

PEPTIDE CORRECTION OF PROTROMBOTIC EFFECTS OF ERYTHROCYTES ON AGGREGATION OF PLATELES

ISTH Academy, Maria Golubeva, 264726

Age-wise variation in expression level of plasminogen activator inhibitor-1 (PAI-1) within platelets sets incidences of thrombotic disorders

ISTH Academy, Ram Lala Mallick, 264742

Comparison of anucleated and nucleated platelet transcriptomes

ISTH Academy, Farzana Ferdous, 264743

Gradient dependent inhibition of platelet stimulatory G-Protein coupled receptors is mediated through cAMP dependent pathway

ISTH Academy, Ankit S Macwan, 264744

Inflammatory Responses in Mice Deficient for Platelet α-granules During Intestinal Ischemia Reperfusion Injury

ISTH Academy, Katrina Ashworth, 264759

PDI regulation of neutrophil Mac-1 function by allosteric disulphides in the β2 subunit

ISTH Academy, Joyce Chiu, 264760

Combining a novel GPVI inhibitor ACT017 with conventional antiplatelet therapy provides greater inhibition of platelet-leukocyte aggregate formation

ISTH Academy, Mark Thomas, 264761

Extension of non-clinical safety margins for recombinant ADAMTS13 (TAK-755/SHP655)

ISTH Academy, Werner Hoellriegl, 264777

Characterization of von Willebrand Factor and ADAMTS13 in the Tim Townes mouse model of sickle cell disease

ISTH Academy, Werner Hoellriegl, 264778

Evaluation of a rapid, fully-automated ADAMTS13 activity assay

ISTH Academy, Josep Serra, 264779

Rituximab prophylaxis in acquired Thrombotic Thrombocytopenic Purpura improves thrombus formation by shear flow-based assay

ISTH Academy, Marie Scully, 264794

A Survey on the use of rituximab in Korean patients with acquired thrombotic thrombocytopenic purpura

ISTH Academy, Sung-Hyun Kim, 264795

A case of hereditary thrombotic thrombocytopenic purpura

ISTH Academy, Li Zhou, 264796

Quality of initial anticoagulant treatment is not a risk factor for developing chronic thromboembolic pulmonary hypertension after acute pulmonary embolism

ISTH Academy, Duliëtte Boon, 264810

Contrast enhanced computed tomography has a high sensitivity for diagnosing chronic thromboembolic pulmonary hypertension

ISTH Academy, Eli Westerlund, 264811

Can a 9-item modified villalta score adequately predict post thrombotic syndrome? A subgroup analysis from the ‘Follow-up In Rivaroxaban patients in Setting of Thromboembolism’ (FIRST) Registry

ISTH Academy, Vicky Speed, 264813

MAC Project - Monitoring Anticoagulant Therapy Observational Study - Rationale and Protocol

ISTH Academy, Giuseppe Camporese, 264828

Absence of Interaction Between Rivaroxaban, Tacrolimus And Everolimus In Renal Transplant Recipients Anticoagulated For Proximal Deep Vein Thrombosis Or Atrial Fibrillation

ISTH Academy, Giuseppe Camporese, 264829

Time in Therapeutic Range (TTR) of Ghanaian VTE Patients on Warfarin

ISTH Academy, Edeghonghon Olayemi, 264830

Identifying patient values and expectations for pulmonary embolism CT scanning in the emergency department

ISTH Academy, Vidushi Swarup, 264844

Complication Rates after Upper Extremity Venous Thrombosis: a Systematic Review and Meta-analysis

ISTH Academy, Rick Ikesaka, 264845

Thrombin Generation during bleeding in orally anticoagulated patients: reversal can lead to hypercoagulability

ISTH Academy, Aurelien Lebreton, 264846

Dabigatran Etexilate : efficacy and safety in the treatment of localized intravascular coagulopathy associated with venous malformations

ISTH Academy, Cedric Hermans, 264861

Management of anticoagulant therapy around delivery: results from the ongoing Highlow study

ISTH Academy, Ingrid Bistervels, 264862

A quality improvement program to reduce the use of inferior vena cava filters for unnecessary indications in a tertiary care center

ISTH Academy, Tzu Fei Wang, 264863

High titer of false positive venereal disease research laboratory (f+VDRL) test among patients with Obstetric Antiphospholipid Antibodies Syndrome (OAPS) having triple positivity profile of antiphospholipid antibodies (aPL)

ISTH Academy, Silvia Peres, 264884

Glycoprotein VI (GP6) single nucleotide polymorphisms affect recurrent pregnancy loss(RPL)

ISTH Academy, Jeong Yong Lee, 264885

Study of utilisation of combined hormonal contraceptives in Europe

ISTH Academy, Deeksha Khialani, 264886

Outcome of pregnancies inadvertently conceived during rivaroxaban anticoagulation therapy - case series

ISTH Academy, Justyna Teliga-Czajkowska, 264903

The changes in platelet function during the three trimesters of uncomplicated pregnancy and puerperium compared to non-pregnant controls

ISTH Academy, Anne Riddell, 264904

The impact of glycemic control in pregnant women with gestational and pregestational diabetes on coagulation status and lipid metabolism

ISTH Academy, Justyna Teliga-Czajkowska, 264905